Supplementary Materials from Validation of the 12-gene Predictive Signature for Adjuvant Chemotherapy Response in Lung Cancer
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table S1. Summary of Tables and Figures. Supplementary Table S2. Propensity score-matched coefficients for each variable using logistic regression. Supplementary Table S3. Propensity score matching results. In Supplementary Table 4. The numbers of patients with and without ACT by stage after propensity score matching in ADC and SCC patient groups. Supplementary Table S5. The dynamic range and correlation between expression levels measured in 30 pairs of FFPE and frozen samples of each gene measured by the nCounter gene expression assay. Supplementary Table S6. Multivariate analysis for validating the prognostic performance of the 12-gene signature measured from FFPE samples after adjusting for other patient characteristics in the 147 stage I ADC patients without ACT. Supplementary Figure S1. Determining the cutoff value of pre-defined risk scores for predicted high-risk and low-risk groups using the assay development cohort. Supplementary Figure S2. (C) Time-dependent ROC curves in (A) ADC patients and (B) stage I ADC patients. Supplementary Figure S3. The ROC curve for the predictive analysis.
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361929630